Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01430221 · ClinicalTrials.gov registry record · NA

Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
140
Enrollment target

NCT01430221: Completed NA study, sponsored by Duke University.

NCT01430221 is a NA study that has completed, run by Duke University. The registered enrollment target is 140 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01430221, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
140 participants
Enrollment target

Study Summary

The purpose of this study is to compare the effectiveness of educational and lifestyle intervention programs aimed at reducing fasting blood sugar and emotional distress in adults with prediabetes.

Primary Outcome

Changes from entry levels of fasting glucose up to 45-days post-intervention, and long-term follow-up (\>6-months) levels.

Interventions

  • BEHAVIORAL Mindfulness-based Personalized Health Planning
  • OTHER Structured & Guided Education

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2011-05
Est. Completion 2017-02-15
Phase NA
Duke University

1,725 total trials

What the finished NCT01430221 record still lists

NCT01430221 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which Mindfulness-based Personalized Health Planning is the first listed.

NCT01430221 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01430221 about?

NCT01430221 is a clinical study titled "Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes". The purpose of this study is to compare the effectiveness of educational and lifestyle intervention programs aimed at reducing fasting blood sugar and emotional distress in adults with prediabetes.

What is the current status of trial NCT01430221?

This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2011-05. Estimated completion is 2017-02-15.

What interventions are being tested in trial NCT01430221?

The interventions under investigation include: Mindfulness-based Personalized Health Planning (BEHAVIORAL), Structured & Guided Education (OTHER).

Who is sponsoring clinical trial NCT01430221?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01430221's enrollment target sits among peer trials

140 713th of 2000 higher than 1,281 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01419561 · 140 participants · Phase 2

    Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

  • NCT01624805 · 140 participants · Phase 2

    Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

  • NCT02369770 · 140 participants · NA

    Sensory-Motor Rehabilitation Post Stroke

  • NCT02455193 · 140 participants · NA

    Neuronal Effects of Exercise in Schizophrenia

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01430221, the US trial registry maintained by the National Library of Medicine. NCT01430221 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.